103
Views
20
CrossRef citations to date
0
Altmetric
Original Research

LncRNA EMX2OS, Regulated by TCF12, Interacts with FUS to Regulate the Proliferation, Migration and Invasion of Prostate Cancer Cells Through the cGMP-PKG Signaling Pathway

, , , , &
Pages 7045-7056 | Published online: 21 Jul 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (19)

Xun Li, Bide Liu, Shuheng Wang, Qiang Dong & Jiuzhi Li. (2024) EDNRB inhibits the growth and migration of prostate cancer cells by activating the cGMP-PKG pathway. Open Medicine 19:1.
Crossref
Zhou Sun, Jie Wang, Zheqi Fan, Yongjin Yang, Xiangdi Meng, Zhaosen Ma, Jiqiang Niu, Rui Guo, Lisa Jia Tran, Jing Zhang, Tianxiao Jiang, Yunfei Liu, Qiwei Yang & Baoluo Ma. (2023) Investigating the prognostic role of lncRNAs associated with disulfidptosis‐related genes in clear cell renal cell carcinoma. The Journal of Gene Medicine 26:1.
Crossref
Dongchao Xu, Ajuan Liu, Qiang Liu, Hongchen Zhang, Mengyao Tian, Ying Bian, Xiaofeng Zhang, Meidan Ying & Hongzhang Shen. (2023) Cucurbitacin C suppresses the progression of pancreatic ductal adenocarcinoma via inhibition of the cGMP-PKG-VASP axis. Biochemical Pharmacology 217, pages 115810.
Crossref
Cheng-Peng Gui, Jin-Huan Wei, Chi Zhang, Yi-Ming Tang, Guan-Nan Shu, Rong-Pei Wu & Jun-Hang Luo. (2023) Single-cell and spatial transcriptomics reveal 5-methylcytosine RNA methylation regulators immunologically reprograms tumor microenvironment characterizations, immunotherapy response and precision treatment of clear cell renal cell carcinoma. Translational Oncology 35, pages 101726.
Crossref
Jamie N. Bakkum-Gamez, Mark E. Sherman, Seth W. Slettedahl, Douglas W. Mahoney, Maureen A. Lemens, Shannon K. Laughlin-Tommaso, Matthew R. Hopkins, Ann VanOosten, Viji Shridhar, Julie K. Staub, Xiaoming Cao, Patrick H. Foote, Megan A. Clarke, Kelli N. Burger, Calise K. Berger, Maria C. O'Connell, Karen A. Doering, Karl C. Podratz, Christopher C. DeStephano, J. Kenneth Schoolmeester, Sarah E. Kerr, Nicolas Wentzensen, William R. Taylor & John B. Kisiel. (2023) Detection of endometrial cancer using tampon-based collection and methylated DNA markers. Gynecologic Oncology 174, pages 11-20.
Crossref
Wenshuai Li, Yingxuan Zhan, Chong Peng, Zhan Wang, Tiantian Xu & Mingjun Liu. (2023) A model based on immune-related lncRNA pairs and its potential prognostic value in immunotherapy for melanoma. Functional & Integrative Genomics 23:2.
Crossref
Lina Ma, Lu Zhang, Lin Li & Li Zhao. (2023) The function of lncRNA EMX2OS/miR-653-5p and its regulatory mechanism in lung adenocarcinoma. Open Medicine 18:1.
Crossref
Hong-Mei Zhang, Ming-Yu Cui & Zhi-Hong Chen. (2023) EMX2OS targeting IGF2BP1 represses Wilms’ tumour stemness, epithelial–mesenchymal transition and metastasis. Journal of Genetics 102:1.
Crossref
Sepideh Mirzaei, Mahshid Deldar Abad Paskeh, Elena Okina, Mohammad Hossein Gholami, Kiavash Hushmandi, Mehrdad Hashemi, Azuma Kalu, Ali Zarrabi, Noushin Nabavi, Navid Rabiee, Esmaeel Sharifi, Hassan Karimi-Maleh, Milad Ashrafizadeh, Alan Prem Kumar & Yuzhuo Wang. (2022) Molecular Landscape of LncRNAs in Prostate Cancer: A focus on pathways and therapeutic targets for intervention. Journal of Experimental & Clinical Cancer Research 41:1.
Crossref
Yi-fang Jiang, Shan-na Wei, Nan Geng, Wen-wen Qin, Xin He, Xiu-huan Wang, Yao-pu Qi, Shan Song & Ping Wang. (2022) Evaluation of circulating small extracellular vesicle-derived miRNAs as diagnostic biomarkers for differentiating between different pathological types of early lung cancer. Scientific Reports 12:1.
Crossref
Zerong Chen, Zehai Huang, Jialiang Hui, zhuangfei Chen, Haibo Zhang, Yaodong Jiang & Weisen Zeng. (2022) Construction and Characterization of n6-Methyladenosine-Related lncRNA Prognostic Signature and Immune Cell Infiltration in Kidney Renal Clear Cell Carcinoma. Journal of Oncology 2022, pages 1-10.
Crossref
Ning Wang, Ying Yu, Rongjiang Wang, Yu Chen & Jianer Tang. (2022) mRNA-Modified FUS/NRF2 Signalling Inhibits Ferroptosis and Promotes Prostate Cancer Growth. Computational and Mathematical Methods in Medicine 2022, pages 1-11.
Crossref
Zi-Qian Liang, Rong-Quan He, Jia-Yuan Luo, Zhi-Guang Huang, Jie Li, Lu-Yang Zhong, Jun-Hong Chen, Su-Ning Huang, Lin Shi, Kang-Lai Wei, Jiang-Hui Zeng, Jing-Jing Zeng & Gang Chen. (2022) Downregulated Dual-Specificity Protein Phosphatase 1 in Ovarian Carcinoma: A Comprehensive Study With Multiple Methods. Pathology and Oncology Research 28.
Crossref
Wenli Mao, Qingzhen Yu, Kefeng Wang, Qiang Ma, Yuxin Zheng, Guojun Zhang, Wei Luo, Nianwu Wang & Yukun Wang. (2022) Comprehensive Analysis of the Transcriptome-wide m6A Methylome in Lung Adenocarcinoma by MeRIP Sequencing. Frontiers in Oncology 12.
Crossref
Xian Tan, Minghang Zou, Di Wu, Jingbo Zhang, Pingping Sun & Zhiqiang Ma. (2021) A Novel Approach for LncRNA Function Prediction Based on Deep Learning. A Novel Approach for LncRNA Function Prediction Based on Deep Learning.
Weiwei Li, Xiurong Yin, Yani Yan, Cong Liu & Gang Li. (2021) STEAP4 knockdown inhibits the proliferation of prostate cancer cells by activating the cGMP-PKG pathway under lipopolysaccharide-induced inflammatory microenvironment. International Immunopharmacology 101, pages 108311.
Crossref
Samira Molaei Ramshe, Hamid Ghaedi, Mir Davood Omrani, Lobat Geranpayeh, Behnam Alipour & Soudeh Ghafouri-Fard. (2021) Up-regulation of FOXN3-AS1 in invasive ductal carcinoma of breast cancer patients. Heliyon 7:10, pages e08179.
Crossref
Zhihao Zou, Ren Liu, Yingke Liang, Rui Zhou, Qishan Dai, Zhaodong Han, Minyao Jiang, Yangjia Zhuo, Yixun Zhang, Yuanfa Feng, Xuejin Zhu, Shanghua Cai, Jundong Lin, Zhenfeng Tang, Weide Zhong & Yuxiang Liang. (2021) Identification and Validation of a PPP1R12A-Related Five-Gene Signature Associated With Metabolism to Predict the Prognosis of Patients With Prostate Cancer. Frontiers in Genetics 12.
Crossref
Hualin Chen, Yang Pan, Xiaoxiang Jin & Gang Chen. (2021) Identification of a Four Hypoxia-Associated Long Non-Coding RNA Signature and Establishment of a Nomogram Predicting Prognosis of Clear Cell Renal Cell Carcinoma. Frontiers in Oncology 11.
Crossref